San Francisco, CA – The Department of Industrial Relations’ Division of Workers’ Compensation (DWC) recently issued modified proposed regulations to adopt the Medical Treatment Utilization Schedule (MTUS) Drug Formulary. The proposed rulemaking implements Assembly Bill 1124 (Statutes 2015, Chapter 525), which mandates adoption of an evidence-based drug formulary.
DWC has reviewed comments received during the first 15-day comment period and has modified the proposed regulations to provide additional detail and clarity. The second 15-day public comment period will end September 22, 2017. Members of the public may submit written comments on the proposed regulations until 5 p.m. that day.
Some of the changes proposed in the revised regulations include:
- Added language clarifying that a compounded drug is subject to the compounded drug regulation even if it includes an active ingredient listed as “Exempt” on the MTUS Drug List
- Removed a provision relating to repackaged drugs
- Updated MTUS Drug List header text to match the regulatory language on the Perioperative period definition
- The notice of modification of text of proposed regulation and related rulemaking documents are posted on the DWC rulemaking web page.
More information about the rulemaking process is posted on the Office of Administrative Law’s website.
Source: CA DWC